Zenas Biopharma director Christy J. Oliger files initial beneficial ownership statement
ZBIO•Initial Form 3 filing
- Zenas Biopharma director Christy J. Oliger filed an initial Form 3 on Sept. 2, 2026.
Related News
BMO launches normal-course buyback for up to 25 million shares
BMO•
Garrett Motion to present at Jefferies Global Industrials Conference
GTX•
Sensient expands receivables securitization facility to $115 million
SXT•
Bank Of Montreal Receives Regulatory Approvals For Normal Course Issuer Bid
BMO•
US-Iran strikes raise fears of renewed war across the Middle East
SPY•